Financial Counselors Inc. decreased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.3% during the third quarter, HoldingsChannel.com reports. The firm owned 90,063 shares of the pharmacy operator’s stock after selling 2,098 shares during the period. Financial Counselors Inc.’s holdings in Walgreens Boots Alliance were worth $6,566,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Asset Dedication LLC increased its holdings in Walgreens Boots Alliance by 204.6% in the third quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock worth $115,000 after buying an additional 1,060 shares during the last quarter. BlueMountain Capital Management LLC acquired a new position in Walgreens Boots Alliance in the second quarter worth approximately $103,000. CSat Investment Advisory L.P. acquired a new position in Walgreens Boots Alliance in the second quarter worth approximately $104,000. Squar Milner Financial Services LLC acquired a new position in Walgreens Boots Alliance in the second quarter worth approximately $106,000. Finally, Kaizen Advisory LLC increased its holdings in Walgreens Boots Alliance by 128.6% in the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 1,083 shares during the last quarter. Hedge funds and other institutional investors own 64.81% of the company’s stock.
Shares of WBA stock opened at $79.90 on Friday. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $80.68. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82. The company has a market cap of $74.79 billion, a price-to-earnings ratio of 13.27, a P/E/G ratio of 1.23 and a beta of 1.04.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The company had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. On average, sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 6.53 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be given a $0.44 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 annualized dividend and a dividend yield of 2.20%. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
A number of research firms recently commented on WBA. Pivotal Research increased their price objective on Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a report on Monday, October 15th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 price objective on the stock in a report on Saturday, October 13th. Barclays increased their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a report on Friday, October 12th. Robert W. Baird increased their price target on Walgreens Boots Alliance from $69.00 to $71.00 and gave the company a “neutral” rating in a report on Friday, October 12th. Finally, Citigroup increased their price target on Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a report on Friday, October 12th. One analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $78.22.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Story: Compound Annual Growth Rate (CAGR)
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.